Product Description
Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. Nortriptyline is an antidepressant that falls under the pharmacological category of tricyclics (secondary amine), more commonly known as TCAs. (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK482214/)
Mechanisms of Action: NRI Inhibitor, SRI Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Bangladesh | Belgium | Brazil | Canada | Chile | Cyprus | Czech | Denmark | Egypt | Estonia | Finland | Hong Kong | Iceland | India | Ireland | Israel | Italy | Korea | Latvia | Lithuania | Malta | Mexico | Netherlands | New Zealand | Norway | Pakistan | Peru | Portugal | Singapore | Spain | Sweden | Taiwan | Thailand | United Kingdom | United States | Uruguay
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
08/12/2024 |
News Article |
Global Substance Abuse Treatment Market to hit $22.8 billion, Globally, by 2031 at 8.6% CAGR, says Coherent Market Insights |
|
01/19/2022 |
News Article |
National Headache Foundation Position Statement on the Treatment of Migraine |
|
12/28/2021 |
News Article |
AAN Issues Guideline for Treatment of Painful Diabetic Neuropathy |
|
09/23/2021 |
News Article |
Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation |